What You Should Know:
- Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care announces the availability of NorstellaLinQ on the Atropos Evidence Network.
- Norstella, one of the largest global pharma intelligence solution providers, is already adopting Atropos Health's Generative AI platform, GENEVA OS™ (Generative Evidence Acceleration Operating System) and is further expanding its partnership with Atropos Health
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Zest Health Raises $13M to Transform Inflammatory Skin Disease Care with Virtual, Value-Based Approach
What You Should Know:
- Zest Health, a leading innovator in virtual dermatology care, today announced a $13 million seed funding round led by Roivant Health.
- The company's AI-powered platform provides personalized care for patients with inflammatory skin diseases like eczema and psoriasis, reducing unnecessary medication use and improving clinical outcomes. The investment will support Zest Health's expansion and enable the company to scale its partnerships with health plans
Read More
Helix Launches Largest Clinico-Genomic Data Cohort to Optimize GLP-1’s
What You Should Know:
- Helix, a leader in population genomics and precision health, today announced the launch of a new clinico-genomic dataset comprising over 15,000 patients treated with glucagon-like peptide-1 (GLP-1) agonists.
- These medications, which include semaglutide, tirzepatide, and liraglutide, are increasingly used to treat type 2 diabetes, obesity, and other metabolic conditions.
GLP-1 Agonist Virtual Registry
This research-ready dataset, known as a
Read More
Vantive Launches as Independent Vital Organ Therapy Company
What You Should Know:
- Vantive, formerly known as Baxter Kidney Care, today announced its launch as a new standalone company focused on vital organ therapies.
- The formation follows the completion of its acquisition by funds managed by Carlyle (NASDAQ: CG) from Baxter International Inc. (NYSE: BAX). Building on a 70-year legacy of innovation in kidney care, Vantive is committed to extending lives and expanding possibilities for patients with kidney disease and other vital
Read More
Press Ganey Partners with Microsoft to Develop GenAI Solutions
What You Should Know:
- Press Ganey, the leading provider of experience measurement, data analytics, and insights for health systems and health plans, has announced a strategic collaboration with Microsoft.
- This collaboration will enable the development of a suite of generative AI-powered solutions that redefine actionable insights, driving transformational improvements in the safety, quality, and experience of care delivery.
Press Ganey and Microsoft
Read More
M42 and Rhapsody Partner to Advance Precision Medicine and Global Health Interoperability
What You Should Know:
- Global health leader M42, which is powered by artificial intelligence (AI) and technology, has announced a groundbreaking partnership with Rhapsody, a leading digital health enablement platform, to empower precision medicine initiatives across the UAE and beyond.
-This collaboration, powered by Microsoft Azure, aims to redefine healthcare data integration and enhance global health outcomes by delivering cutting-edge solutions for seamless and scalable
Read More
Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities
What You Should Know:
- Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
- The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare, making it more accessible and affordable for healthcare providers and patients.
AI-Powered Lung Nodule Analysis
Lung cancer remains a leading cause of cancer-related deaths worldwide, but screening rates remain
Read More
Medsender Raises $5M for AI-Powered Workflow Automation Platform
What You Should Know:
- Medsender, the AI-powered workflow automation platform for healthcare providers, is pleased to announce a recent $5 million Series A investment led by Ballast Point Ventures.
- Medsender will use the investment to bolster its commercial team, accelerate its technology pipeline development, and drive industry-leading performance for its clients.
Medsender: AI-Powered Workflow Automation for Healthcare
Medsender is an advanced workflow automation platform
Read More
Cellular Connectivity: The Future of Home Medical Devices
The global home medical equipment market is experiencing explosive growth. Smart devices are being used to monitor and treat patients suffering from diabetes, cardiac disorders, and other medical conditions without exposing those patients to the risk of hospital-acquired infections. Numerous organizations, including the World Health Organization and the National Council of Aging, are promoting self-health management to give patients better outcomes.
This trend leverages digital technology to
Read More
Navigating FDA’s New Guidance on Medical Device Servicing
The complexity and cost of medical devices are escalating, and with it, the stakes for maintaining these assets efficiently and compliantly are increasing. In some cases, this requires complex and comprehensive repairs that may involve major components of the asset being rebuilt or upgraded. As organizations strive to prolong the safe, useful lifespan of their medical assets while curtailing capital expenditure, they face a new challenge: adhering to the U.S. Food & Drug Administration’s
Read More
